|
SLC29A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.198200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.400180E-04 |
| Normal-vs-Stage2 |
2.495400E-03 |
| Normal-vs-Stage3 |
1.060120E-02 |
| Normal-vs-Stage4 |
1.679960E-01 |
| Stage1-vs-Stage2 |
5.333600E-01 |
| Stage1-vs-Stage3 |
4.110800E-01 |
| Stage1-vs-Stage4 |
8.598400E-02 |
| Stage2-vs-Stage3 |
2.769000E-01 |
| Stage2-vs-Stage4 |
8.114100E-02 |
| Stage3-vs-Stage4 |
3.185400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.101480E-03 |
| Normal-vs-AfricanAmerican |
7.237600E-02 |
| Normal-vs-Asian |
9.004800E-01 |
| Caucasian-vs-AfricanAmerican |
6.068200E-01 |
| Caucasian-vs-Asian |
5.236800E-03 |
| AfricanAmerican-vs-Asian |
1.993990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.642490E-03 |
| Normal-vs-Female |
2.829100E-04 |
| Male-vs-Female |
9.835800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.460640E-03 |
| Normal-vs-Age(41-60Yrs) |
1.523720E-03 |
| Normal-vs-Age(61-80Yrs) |
2.684500E-03 |
| Normal-vs-Age(81-100Yrs) |
3.696000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.689200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.657800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.647800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.386200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.850800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.043600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.543200E-01 |
| Classical-VS-Follicular |
1.80110000003175E-06 |
| Classical-VS-Other |
2.660100E-02 |
| Classical-VS-Normal |
2.210500E-02 |
| Tall-VS-Follicular |
2.479900E-03 |
| Tall-VS-Other |
1.655860E-02 |
| Tall-VS-Normal |
1.463760E-01 |
| Follicular-VS-Other |
5.177800E-01 |
| Follicular-VS-Normal |
7.29329999726858E-08 |
| Other-VS-Normal |
4.427100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.31390000000098E-05 |
| Normal-vs-N1 |
7.175600E-03 |
| N0-vs-N1 |
8.819200E-01 |
|
|
